Medexus Pharmaceuticals Inc
Research Medexus Pharmaceuticals Inc (MDP) on Bullrun: market cap CAD 151.47M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMDP
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCAD
- Market capCAD 151.47M
- Financial periodQ1 2026
- RevenueUSD 24.65M
- Net income-USD 2.68M
- Free cash flow-USD 11.22M
- Gross margin53.8%
Valuation Snapshot
latest market cap is CAD 151.47M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 108.33M | USD 2.25M | USD 21.31M | 52.2% | 0.08 | USD 23.97M | USD 37.18M | USD 52.14M |
| FY2024 | USD 113.05M | -USD 214.00K | USD 18.45M | 52.6% | -0.01 | USD 5.26M | USD 49.90M | USD 30.32M |
| FY2023 | USD 108.10M | USD 1.22M | -USD 1.81M | 55.5% | 0.06 | USD 13.07M | USD 70.08M | USD 22.45M |
| FY2022 | USD 76.70M | -USD 2.88M | -USD 8.89M | 49.4% | -0.15 | USD 10.02M | USD 54.86M | USD 17.79M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-13 | CAD 151.47M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis, psoriasis, and juvenile idiopathic arthritis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Medexus Pharmaceuticals Inc's market cap?
Medexus Pharmaceuticals Inc's market capitalization is CAD 151.47M.
What does Medexus Pharmaceuticals Inc do?
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases.